Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sandra A. Gardiner resigned as Acting Chief Financial Officer at Anebulo Pharmaceuticals, Inc..
- Action
- resigned
- Role
- Acting Chief Financial Officer
Exact text from the filing
On August 29, 2023, in connection with the termination of the Master Services Agreement, Sandra A. Gardiner notified the Company of her resignation as the Company’s Acting Chief Financial Officer, including as the Company’s principal financial officer and principal accounting officer, effective as of the Termination Date.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.97
Anebulo Pharmaceuticals, Inc. terminated Master Services Agreement with Potrero Hill Advisors, LLC valued at Termination of Master Services Agreement effective September 28, 2023 (effective 2023-09-28).
- Action
- termination
- Counterparty
- Potrero Hill Advisors, LLC
- Value
- Termination of Master Services Agreement effective September 28, 2023
- Effective
- 2023-09-28
Exact text from the filing
Item 1.02 Termination of a Material Definitive Agreement. On August 29, 2023, Potrero Hill Advisors, LLC (“Potrero”) provided written notice to terminate that certain Master Services Agreement, dated as of March 2, 2023, by and between Anebulo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Potrero (the “Master Services Agreement”), effective as of September 28, 2023 (the “Termination Date”).
View on SEC.gov